- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Future of the ACA and Plans to Repeal: Dr Patricia Salber Interviews Dr Joe Antos
There are a lot of unknowns about how Republicans will move to repeal and replace the Affordable Care Act now that they will have a Republican in the White House. Joe Antos, PhD, resident scholar at the American Enterprise Institute, did his best to speculate how a repeal might play out and what will happen with Medicaid expansion under a Trump presidency.
There are a lot of unknowns about how Republicans will move to repeal and replace the Affordable Care Act now that they will have a Republican in the White House. Joe Antos, PhD, resident scholar at the American Enterprise Institute, did his best to speculate how a repeal might play out and what will happen with Medicaid expansion under a Trump presidency.
Listen below or through one of these podcast services:
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More
